




The thesis entitled “Studies towards the synthesis of (-)-Ushikulide-A, (-)-Aspergillide-B 
and chiral β-hydroxy ketones” is divided into three chapters. 
Chapter I: This chapter deals with studies towards the synthesis of (-)-Ushikulide-A (1) 
 (-)-Ushikulide A (1) exhibits potent activity against murine splenic lymphocyte 
proliferation (IC50) 70 nM), rivalling that of the well-known cyclosporin A2 and FK506,3 
which revolutionized organ transplant therapy by suppressing rejection, was isolated from a 
culture broth of Streptomyces sp. IUK- 102 by Takahashi et al.,
1
 in 2005.  
Figure 1 
 
From the retrosynthetic analysis of 2 (Scheme 1), the formation of the spiroketal 
segment (2) of Ushikulide-A (1) was envisaged through an acid catalyzed one pot 
desilylation and spiroketalization via double intramolecular hetero Michael addition 
(DIHMA)
2 
on the linear ynone 3 as key step to construct the spiroketal moiety. In turn, 
ynone 3 was planned by the assembly of two fragments alkyne 4 and aldehyde 5, which in 
turn could be prepared from 6 and 7 respectively. The alkyne 4 serves as a stabilized anion, 
which undergoes addition with aldehyde 5. The alkyne in ynone 3 then acts as an 
electrophile in acid catalyzed DIHMA reaction.  
Scheme 1: Retrosynthetic analysis 





 Alkyne 4 has been synthesized from known  alcohol 6.
3
 Accordingly 6 on treatment 
with BnBr, NaH in THF gave corresponding benzyl ether  in 58% yield, which on 
ozonolysis in CH2Cl2 at -78 ºC gave aldehyde 8 in quantitative yield.  Aldehyde 8 on 
propargylation with 14a under Marshall conditions
 4
 furnished 9 in 78% yield (94:6 de) . 
The secondary hydroxy group in single diastereomer 9 was subsequently protected as silyl 
ether on treatment with TBDMS-Cl and imidazole to furnish 10 in 78% yield, which on 
formylation with para formaldehyde using  EtMgBr furnished propargyl alcohol 11(69%), 
which on hydrogenation with PtO2 in EtOAc gave saturated alcohol 12 in 91% yield.  
Oxidation of 12 with Dess–Martin periodinane
5 
gave the aldehyde in quantitative yield, 
which was subsequently treated with CBr4 and PPh3 to furnish dibromoolefin in good yield. 
Finally the dibromoolefin on treatment with n-BuLi under Coey-Fuchs conditions
6
 gave the 
alkyne 4 in 80% yield. 
 Aldehyde 5 has been synthesized from known epoxy alcohol 7, Accordingly epoxy 
alcohol under Gillmann
7
 condition gave 1,3 diol 15 in 66% yield, which on treatment with 






 Selective deprotection of primary TBDMS ether with HF-Pyridine furnished 
primary alcohol 17 in 71% yield. Oxidation of 10 with Dess–Martin periodinane gave the 
aldehyde 5 in 96% yield (Scheme 3). 
 Synthesis of ynone 3 (Scheme 4) began with the coupling of lithium acetylide 
derived from 4 with 5 to afford a mixture of propargylic alcohol 18 in 54% yield, which on 
oxidation with Dess-Martin periodinane gave the ynone 3 in 84% yield. Cleavage of the 
TBDMS groups in 2 with CSA in MeOH and subsequent treatment with p-TsOH in toluene 
at room temperature for 24 h cleanly affected the spiroketal formation under DIHMA 
conditions and furnished diastereomeric spiroketal mixture 1 in 58% yield. 
 
 In summary synthesis of spiroketal fragment of ushikulide-A accomplished by a 
divergent route that involves Double Intramolecular hetero Michael addition for the 
construction of spiroketal fragment, Marshall propargylation for the creation of syn C24, 
C25 centers, Corey-Futch reaction for the synthesis of terminal alkyne. 
Chapter II: This chapter deals with studies towards the synthesis of Aspergillide-B 
 Aspergillides A-C (19a-c) were isolated from the marine fungus Aspergillus 
ostianus by Kusumi and co-workers.
8
 These natural products are characterized by a 14-
membered macrolactone core structure embedded with a 2,3,6-trisubstituted 
tetrahydropyran ring and the first examples of 14-membered macrolides that possess 





have four stereocentres (3S, 4S, 6R, 13S) with a 2,6-trans tetrahydropyran, 6-hydroxy  and 
13-methyl moiety.  
Figure 2 
 
The macrolides 19a and 19b showed good cytotoxic activities against mouse 
lymphocytic leukemia cells
 
and five different human cancer cell lines: promyelocytic 
leukemia, breast carcinoma, fibrosarcoma, colon adenocarcinoma and osteosarcoma, as well 
as in a primary culture of non-transformed bovine aorta endothelial cells.  
 From the retrosynthetic analysis of 20 (Scheme 5), the formation of the 14- lactone 
moiety was envisaged through Yamaguchi macrolactonization on the seco acid 21, inturn 
seco acid envisaged by the cross metathesis of  fragments 22, known alcohol 23
9a
. 2,6 
dihydro-2H-pyran 22 was envisaged from  hydroxy ester 24, which inturn synthesized from 
known α, β-unsaturated-γ, δ-epoxy ester 25.  
Scheme 5: Retrosynthetic analysis 
 Pyran 22 was synthesized from known epoxy unsaturated ester 25,
9b 
opening of 
vinyl epoxides with retention of stereochemistry. Only one method that allows opening of 







 Accordingly palladium catalyzed regio- and stereoselective opening of 
epoxy unsaturated ester 25 with retention of configuration by using triphenyl borate and 
benzyl alcohol to give 24 as a single stereoisomer in 52% yield.  The selective reduction of 
olefin 24 by using Mg in MeOH gave 26 in 80% yield. Ester 26 was reduced by using 
DIBAL-H at -78 ᵒC to give lactol in 26a in quantitative yield. Next it was aimed to 
construct key fragment trans-2,6-disubstituted tetrahydro-2H-pyran ring by adopting the 
streategy developed by our group,
11
 Accordingly reaction of  26a with allyltrimethyl silane 
by using I2 in CH2Cl2 gave pyran 27 in 75% yield, which on reaction with DDQ in 
CH2Cl2:H2O (19:1) gave 28 in 81% yield. Isomerisation olefin of 22 was achieved by 
adopting the method developed by Hanessian et  al.
12
 Accordingly treatment of 28 with G-II 
catalyst in MeOH afforded isomerized olefin 22 in 73% yield as an 8:1: E/Z mixture. 
 
 
 The olefin 22 and known alcohol 23
13 
(Scheme 7) were subjected to cross metathesis 
in the presence of Grubbs second generation catalyst in CH2Cl2 at 60 C to give diol 29 in 
70% yield. A subsequent oxidation of the primary alcohol 29 with TEMPO and BIAB 
readily furnished the hydroxy aldehyde 29a in 88% yield, further oxidation of the aldehyde 
29a to the carboxylic acid 21 was accomplished in 68% yield, under the Lindgren-Kraus-
Pinnick condition.
14
 Macrolactonization of the resulting hydroxy-acid 21 was then realized 
under the Yamaguchi protocol. Activation of the acid functionality in 21 with 2,4,6-





dilution conditions in toluene afforded the E-macrolactone 20 in 30% yield.  The spectral 




 -59.22 (c 0.4, CHCl3); 
Lit.
 





 In summary formal synthesis of  the cytotoxic macrolide aspergillide-B 
accomplished by a divergent route that involves Yamaguchi macrolactonization for the 
construction of 14-membered lactone, I2 catalyzed synthesis of trans-2,6-disubstituted 
tetrahydro-2H-pyran sub unit, Pd(0)-triphenyl borate mediated stereoselective epoxide 
opening for the creation of  C4, C5 centers. 
Chapter III: This chapter deals with studies towards the synthesis of chiral β-hydroxy 
ketones 
 The stereoselective aldol is one of the most powerful synthetic methods for the 
synthesis of β-hydroxy carbonyl compounds,
16 
which are subunits of many natural products 
and it has also been utilized in the synthesis of polyoxygenated compounds. Since the first 
report of L-Proline catalyzed enantioselective C-C bond formation
 17
 via an intermolecular 
aldol reaction by List and co-workers,
 18
 there has been a tremendous progress in Proline 
catalyzed direct aldol
 
reactions. A number of catalysts were reported with modified acidic 
moiety of L-proline. The asymmetric direct aldol reaction
 19
 does not require preformed 
enolate thus makes it more atom economical. The major proline derived organocatalysts are 
4-substituted L-proline,
 20 
proline derived N-sulfonyl carboxamides,
21 
small peptides,   
different type of prolinamides
22 
and other chiral aminoacids. 
 A facile enantioselective direct aldol reaction of acetone with various aromatic 






Scheme 8. Direct asymmetric aldol reaction catalyzed by prolinamide A 
 The catalyst 30 was prepared
 
from 8-aminoquinoline (32) and N-Boc-L-proline(33) 
(Scheme 9). We envisaged that L-prolinamide (30) may induce the enantioselectivity owing 
to the stereorigidity within the catalyst (30). The quinoline ring of the catalyst could be 
anticipated to interfere in the transition state of aldol reaction in such a way that it manifests 
the enantioselectivity.  
 
Scheme 9: Synthesis of prolinamide (30) 
 Similarly, other prolinamide derivatives (35and 36) were prepared from N-Boc-L-
proline (33) and the corresponding amines respectively, according to synthetic route as 
shown in Scheme 9. Deprotection of Boc group by 5N HCl in THF:H2O (3:1) afforded the 
prolinamides 35 and 36 in good yields. Accordingly, the catalytic performance of 
prolinamide catalysts (30, 35, 36) were examined in direct aldol reaction between o-
nitrobenzaldehyde (31) and acetone in a variety of solvents without additives at different 
temperatures.  The results are summarized in Table 1. Among those catalyst 30 shown good 
‘ee’ values. Initially, the aldol reaction was performed at room temperature using the 






Figure 3. L-Prolinamide derivatives 
 
 Indeed the catalyst 30 (10 mol%) showed very high reactivity in the aldol reaction of 
acetone with 2-nitrobenzaldehyde (31). The reaction proceeded smoothly at room 
temperature in solvent free conditions. The reaction was completed within 2 h and the 
corresponding product 31a was obtained in 90% yield, but the enantiomeric excess was 
nonetheless low (65%). The reaction conditions were further optimized for catalyst 30 to 
increase the ee. The results, as depicted in Table 2, reveal that the aldol reaction occurs in 
many of organic solvents, but good yield and high enantioseletivity were observed in DMF 
only. Though slight difference in enantioselectivity was observed in THF and CHCl3, the 
reaction took longer reaction times. However, the enantiomeric excess was further 
decreased when water was used as a solvent. By further optimizing the reaction conditions, 
the enantioselectivity was increased to 78% at 0 ºC. By further decreasing the reaction 
temperature to -40 ºC, the product was obtained with 92% ee. It was found that the 
enantioselectivity was dependent on the reaction temperature. The best enantioselectivity 
was obtained in direct aldol reaction by catalyst 30, when temperature was lowered, though 






 This result is presumably due to steric bulkiness in the catalyst, which may play an 
important role in stereoselectivity. Moreover, when the loading of catalyst was decreased 
from 10 mol% to 5 mol% there is no change in enantiomeric excess but the reaction time 
has increased (11 hrs). 
 Next, we examined the scope and generality of this process with various aldehydes 
under optimized conditions. The best results were achieved when  ortho–nitrobenzaldehyde 
was used. Similarly other nitro substituted benzaldehydes also produced the corresponding 
products in good yields with good enantioselectivities. The halo and cyano substituted 
benzaldehydes were also effective for this conversion. In the case of naphthaldehyde, both 
enantioselectivity and yields were moderate. Aliphatic aldehydes are not so effective. 
Therefore, the yields and enantioselectivity were low with aliphatic aldehydes. In the case 





Figure 4:Aldol derivatives from various aldehydes 
 The stereochemistry of the aldol products was assigned by comparing the data with 
the reported values.
20
 On the basis of experimental results, the high stereo control observed 
when using Prolinamide catalyst 30 can be rationalized by involving presumed transition 





Figure 5. Proposed transition state for the aldol reaction  
 In summary, we have synthesized a new prolinamide catalysts for enantioselective 
direct aldol reaction. This method shows moderate to good enantioselectivity at -40 ˚C. Of 
three catalysts, prolinamide 30 was the most efficient for the aldol reaction of acetone with 
various aldehydes. The corresponding β-hydroxy ketones were obtained in good yields (up 
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